FDA approves breakthrough pancreatic cancer drug

The FDA has approved a new drug to treat pancreatic cancer, one of the most difficult cancers to treat with very low survival rates. The approval is being hailed as a breakthrough in oncology. The drug's specifics were discussed by Adam Feuerstein of the health and science outlet STAT.